]choline were similarly metabolized in 9L cells in both normoxic and hypoxic conditions over a 2-h incubation period. In normoxia, radioactivity was predominantly in phosphorylated form for both tracers after 5-min incubation. In hypoxia, the tracers remained mainly in nonmetabolized form at early timepoints (<20 min). 
Introduction
In recent years, alterations of choline uptake and metabolism have come to be recognized as hallmarks of malignancy [1] . High choline uptake and increased choline kinase activity have been reported in many cancers [2] [3] [4] [5] . Choline kinase is known to be overexpressed in lung, colorectal, and prostate cancers [6] . The potential for positron emission tomography (PET) imaging using [ 11 C] choline has been shown in detection of brain tumor [7, 8] , prostate carcinoma [9] , and esophageal carcinoma [10] . However, the short half-life of [ 11 C]choline (T 1/2 =20 min) limits its use to facilities that have a cyclotron within a short distance from the imaging suite. To allow for more practical distribution of a longer-lived tracer, the 18 Flabeled choline analog (T 1/2 =109 min), [ 18 F]fluorocholine ([imaging [11] [12] [13] [14] [15] [16] [17] [18] [19] . However, there is a lack of understanding of the influence of the fluorine atom in [ 18 F]FCH on its biodisposition and metabolism and how its biochemical properties impact the interpretation of the imaging data. Previous work with radiolabeled cholines suggested the importance of the Kennedy pathway beginning with phosphorylation as well as oxidation to betaine (Fig. 1 ) [20] . Therefore, in this study, our primary objective was to compare [ 18 F]FCH and radiolabeled choline with respect to their uptake and metabolism in a tumor-bearing rodent model. To allow access to multiple blood samples for metabolic analysis in a well-characterized tumor model, the 9L-glioma-bearing Fisher 344 rat model was chosen. Because it is known that subcutaneous 9L tumors are hypoxic [21] , we sought to clarify the observations in the 9L tumors by undertaking metabolic studies with the choline radiotracers in normoxic and hypoxic cultured 9L cells. On the basis of structural similarity, we anticipated that [ 18 F]FCH would mimic choline uptake and metabolism in cultured cancer cells, normal tissue, and 9L tumors in rat, resulting in physiologic processing similar to choline. Thus, the purpose of this study was to utilize the 9L-gliomabearing rat model to clarify the metabolic handling of [ 18 F] FCH relative to radiolabeled choline and to clarify the effects of hypoxia on the choline tracer's uptake and metabolism through analytical studies.
Materials and methods
Male Fisher CDF 344 rats were obtained from Charles River Laboratories International, Inc., (Wilmington, MA, USA). 9L glioma cells were from American Type Culture Collection (ATCC; Manassas, VA, USA). [ 14 C]choline (370 MBq/ mmol), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), trishydroxymethylaminomethane (Tris), NaCl, KCl, CaCl 2 , MgCl 2 , glucose, choline, sodium pentobarbital, phosphate-buffered saline (PBS), adenosine triphosphate (ATP), perchloric acid, nicotinamide adenine dinucleotide phosphate, hexokinase, glucose-6-P dehydrogenase, urea, phosphocreatine, creatine phosphokinase, Dowex resin, heparin, ethylene glycol tetraacetic acid, dithiothreitol (DTT), benzamidine, ethylenediaminetetraacetic acid (EDTA), triton X-100, bovine adult serum, N-tosyl-L-phenylalanine chloromethyl ketone (TPCK), trypsin inhibitor, or phenylmethylsulfonyl fluoride (PMSF) leupeptin, and antipain were obtained from Sigma (St. Louis, MO, USA 18 F radioactivity and Beckman Coulter LS6500 scintillation counter was used to count 14 C radioactivity. Z1 Coulter particle Counter and Z-Pack Balanced electrolyte solution was from Beckman Coulter, Fullerton, CA, USA. Dulbecco's modified Eagle's medium (DMEM) and fetal bovine serum were from ATCC (Manassas, VA, USA). Trypsin was obtained from Mediatech Inc. (Herndon, VA, USA). Uptake and metabolism in cultured 9L glioma cells Studies of tracer choline uptake were performed in cultured 9L glioma cells in normoxic and hypoxic conditions. For the latter condition, a 24-h exposure to hypoxia (1% O 2 ) was chosen as a preconditioning period before administration of choline radiotracers because significant changes in protein expression are seen only during prolonged (>16 h) hypoxic (1% O 2 ) exposure [22] . At the end of incubation, the cells were washed three times with chilled PBS. For metabolite analysis, the cells were scraped in 500 μl chloroformmethanol (2:1) and sonicated at 4°C. To the sonicated cell suspension was added to 100 μl aqueous urea (40%) and 100 μl sulfuric acid (5%). The cells were sonicated for another 15 s and then centrifuged at 2,500×g for 5 min at 4°C. Hydrophilic choline metabolites in the aqueous layer were analyzed using gradient high-performance liquid chromatography (HPLC) as described below. Aqueous and organic fractions were separated and counted.
To enhance cellular uptake of choline tracer and the potential production of oxidative metabolites, cells were incubated for 2 h using HEPES-Tris buffer (20 mM HEPES-Tris pH 7.4, 1 mM NaCl, 4 mM KCl, 2.8 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM glucose) containing lower concentration of choline (10 μM). To rule out the possibility of auto-oxidation of choline, a stability test was done by incubating~444 KBq [ 3 H]choline in HEPES-Tris buffer for 1 h. Equal amount of chloroform-methanol (2:1) was added to the buffer and centrifuged at 2,500×g for 5 min to separate aqueous fraction. Hydrophilic choline metabolites in the aqueous layer were analyzed using HPLC.
Cell counting and calculation of doubling time Cell counts and cell doubling time were measured in parallel with the previously described tracer studies. Cells were trypsinized and suspended in a known volume of medium. The cell suspension was diluted 1,000-fold with balanced electrolyte solution. Cells were counted in the diluted suspension using a particle counter. Doubling time was calculated using the formula DT days ð Þ¼T Â 0:693= ln Nf =Ni ð Þ, where DT is time needed to double a cell population, T is the incubation time in days, Ni is the cell number at the beginning of the incubation time and Nf is the cell number at the end of the incubation time. The uptake measurements were normalized to one million cells based on these cell count data.
Pulse-chase experiment
To investigate the efflux rates of radioactivity from 9L glioma cells after initial uptake, a pulse-chase experiment was performed. After 24-h incubation at 37°C under normoxic or hypoxic conditions, the 9L glioma cells were incubated with [ Radioactivity was counted in the PBS washes and the incubation medium after each cycle. The PBS washes and the fresh medium were equilibrated with 21% O 2 (normoxic condition) or 1% O 2 (hypoxic condition). Hydrophilic choline metabolites in the washout were analyzed using HPLC.
ATP measurement ATP concentrations in cultured cells were determined from neutralized perchloric acid cell extracts by a spectrophotometric method [23] .
Choline kinase assay
The cells were scraped and homogenized in chilled extraction buffer pH 7.5 (30 mM HEPES pH 7.5, 3% Triton X-100, 2 mM EDTA, 2% bovine adult serum, 10 μM TPCK, 10 mg/ml trypsin inhibitor, 1 μM leupeptin, 0.75 mg/ml DTT, 0.4 mg/ml PMSF). The cell homogenate was centrifuged for 10,000×g for 20 min at 4°C. The supernatant was used for the assay as described by Ishidate and Nakazawa [24] . The assay mixture (300 μl) contained 0.1 M Tris-HCl, pH 7.5, 10 mM ATP, 12 mM MgCl 2 , 100 μM choline, [ 14 C]choline (∼0.7 MBq per assay mixture). Samples were incubated at 37°C for 30 min.
Biodistribution and metabolite study in 9L-glioma-tumorbearing rat tumor model The 9L-glioma-bearing rat model was chosen for in vivo studies of [ 18 F]FCH metabolism because it is a wellcharacterized tumor model (2) and serial blood sampling for metabolite analysis is practical. Male Fisher CDF 344 rats (~200 g) were anesthetized with sodium pentobarbital (45 mg/kg IP). The thigh area was shaved and 2-3×10 6 cultured 9L glioma cells suspended in 50 μl PBS were inoculated under the skin. The tumor was allowed to grow to the size of approximately 1.5 cm 3 (about 4 weeks). Prior to radiotracer administration, the rat was placed on a warming pad (37°C), a femoral cut-down was performed, and a femoral vein catheter was established for injection of radiotracers. The neck area was incised and a carotid catheter was established (∼50 μl volume prefilled with heparin and plugged at the end). The rat was heparinized by venous injection of 28 units heparin in 50 μl isotonic saline.
Groups of animals (n=4 each) were studied after bolus intravenous administration of [
18 F]FCH (74 MBq) and [ 14 C]choline (1.8 MBq) in isotonic saline. Blood samples were collected from the carotid artery at a rate of two samples per minute over the first 5 min and one sample per 5 min thereafter. At 5 or 20 min after bolus injection, rats were euthanized and tissues excised for radioactivity counting and metabolite analysis. Lung, liver, kidney, and tumor tissue samples were rinsed in chilled saline and blotted to remove excess liquid. A portion of each tissue was weighed and counted for 18 F-radioactivity, while the remainder was used for metabolite analysis. The remaining tissues (brain, heart, skeletal muscle, small and large intestines, bone, colon, prostate, and skin) were rinsed in chilled saline, blotted to remove excess liquid, weighed, and counted for 18 F radioactivity. Urine samples were withdrawn from the bladder with a syringe. Blood samples were centrifuged, and the plasma was separated and counted. 18 F radioactivity in the tissue and plasma samples was allowed to decay for at least 24 h before counting for 14 C radioactivity. Tissues were incubated with 0.5-ml tissue solubilizer (SOLVABLE, Perkin Elmer) at 37°C overnight; 5-ml scintillation cocktail was added, and 14 C-radioactivity was counted.
Analysis of radiolabeled metabolites
Tissue samples were homogenized using a polytron homogenizer in 5 ml chloroform-methanol (2:1) at 4°C. The homogenate was sonicated for 15 s; then, 1 ml aqueous urea (40%) and 1 ml sulfuric acid (5%) was added. The suspension was sonicated for another 15 s. The suspension was centrifuged at 2,500×g for 5 min. Aqueous and organic fractions were separated and counted. Plasma samples were worked up as described above for tissue without homogenization. Samples of the aqueous phase were applied to an Adsorbosphere Silica HPLC column (4.6×250 mm, 10 μ; Alltech Associates, Deerfield, IL, USA). The following gradient was used for the HPLC separation: solvent B in the eluent 0% at 0-3 min, 0-30% at 3-10 min, 30-40% at 10-20 min, 40-100% at 20-22 min, 100% at 22-50 min, 100-0% 50-56 min, and 0% at 56-57 min. Solvent A was acetonitrile-water-ethanol-1 M ammonium acetate-glacial acetic acid (0. Retention times were determined using unlabeled standards of choline, FCH, betaine, fluorobetaine, phosphocholine, and phosphoryl-FCH and mass spectrometry detection (Varian, Palo Alto, CA, USA). 18 F-radioactivity in 100 μl standard of injectate and collected samples were measured in gamma counter. The samples were then allowed to decay for at least 24 h. The injectate and samples in a liquid scintillation counter were counted for 14 C radioactivity.
Statistical analysis
The data were compared using paired or unpaired t-test analyses as appropriate. Differences were regarded as statistically significant for p<0.05.
Results

Cultured 9L glioma cells
In normoxic 9L glioma cells incubated with radiolabeled choline and [ 18 F]FCH, the choline tracers were taken up avidly and rapidly phosphorylated ( Fig. 2 and Table 1 ). The fraction of aqueous soluble radioactivity in the form of phosphocholine was 83%, 95%, and 99% for incubation periods of 5, 20, and 120 min, respectively. By 2-h incubation, approximately 19% of the radioactivity was associated with lipophilic metabolites. Uptake of [ F]FCH by 9L glioma cells over a 2-h period was similar to that of radiolabeled choline ( Fig. 2 and Table 1 ). Furthermore, there were no significant differences in the levels of radiolabeled metabolites generated from the two tracers. Neither of the putative oxidative metabolites, radiolabeled betaine or fluorobetaine, were detected in the cells at 2-h incubation, indicating oxidation of tracer choline and [ In hypoxic (1% O 2 ) conditions, the two choline tracers showed uptakes similar to those seen in normoxic conditions for incubation times up to 20 min (Fig. 2) . However, at 2 h, uptake of the choline tracers was found to be decreased by approximately 50% in hypoxic cells relative to normoxic cells. In contrast with the results in normoxic cells, the major fraction of radioactivity in the aqueous fraction of hypoxic cells at early timepoints was contributed by nonmetabolized radiolabeled choline and [
18 F]FCH (Fig. 2) . However, by 2-h postincubation, 97% of the radioactivity was in the respective phosphorylated forms (Fig. 2) . Thus, hypoxia significantly slowed the rate of intracellular phosphorylation, decreased cellular retention (uptake), but did not decrease the ultimate extent of phosphorylation at later timepoints.
Proliferation rate was slightly slower in the hypoxic cells compared to normoxic cells (hypoxic doubling time=2.2± 0.2 days versus normoxic doubling time=1.8±0.1 days). ATP concentration decreased by 30% and choline kinase activity decreased by 21% in hypoxic 9L glioma cells compared to 9L cells incubated under normoxic conditions (Table 2) .
To , n=3) . Asterisk, p<0.05 versus total uptake in normoxic condition using unpaired t-test. Number sign, p < 0.05 versus metabolite fraction in normoxic condition using unpaired t-test To investigate the potential role of dephosphorylation on the tracer kinetics of radiolabeled cholines, a pulse-chase experiment was performed. After the pulse of radiolabeled choline tracers for 2 h, moderate levels of radioactivity were washed out of the cells in successive 15-min incubations with medium-lacking radioactivity (Fig. 3) . HPLC analysis of the incubation medium during the washout phase showed the radioactivity to be completely in the form of [ 14 F and 14 C radioactivity decreased rapidly within the first 1.5 min postinjection (Fig. 4) . At 0.5 min, higher levels of 18 F radioactivity were seen in plasma as compared to 14 C radioactivity. No change was observed in the plasma concentration of radioactivity after 2 min for both tracers. HPLC analysis of plasma samples collected 2, 5, and 20 min Table 5 shows the radioactivity distribution in aqueous and organic fractions in tumor and major tissues. Lung showed the highest fraction of lipid soluble choline metabolites of all tissues (37.4±7.0% at 20 min), followed by kidney (7.7±4.6%) and liver (5.2±0.9%). Lipophilic metabolites increased from 5 to 20 min postinjection with corresponding decreases in aqueous soluble metabolites in all the major tissues except tumor. In all the tissues studied, moderately higher amounts of 14 C radioactivity were seen in the lipophilic fractions as compared to 18 (Fig. 2) .
Discussion
Techniques for noninvasive imaging of cancer using PET are typically based on preferential binding or metabolic ]FCH into membrane phospholipids of cultured cells was also found to be minimal for incubation periods up to 2 h. Thus, phosphorylation of choline tracers was the major step of metabolism that accounted for accumulation of radioactivity in the cultured 9L cells.
The pulse-chase experiment showed higher washout rates for [
14 C]choline than [ 18 F]FCH under both normoxic and hypoxic conditions. Because >95% of the radioactivity was in the form of the radiolabeled phosphorylated cholines 3 H]choline in guinea pigs showed the half-life of choline in plasma to be less than 1 min and the rapid removal of choline was accomplished mainly by kidney and liver.
The high accumulation of choline radiotracers in kidney and liver reflects the important role of these organs in choline metabolism in the body. Kidney and liver are known to be the major sites for oxidation of choline to betaine [20, 25] . Betaine is an important donor of methyl groups for formation of methionine [26] which is used for the synthesis of S-adenosyl methionine. In the kidney, betaine serves as an osmolyte [27] . Some betaine is also transported from the kidney to other organs for use as an osmolyte or methyl donor. The rapid uptake and clearance of the choline tracers in liver and kidney indicate the importance of tissue perfusion on their biodistribution.
There was an observed trend toward higher urinary excretion of [ 18 ]choline were nearly an order of magnitude higher than those found in liver and kidney. Although these fractions were not chemically identified, it is assumed that they represent incorporation of radioactivity into phospholipid metabolites, including phosphatidylcholine. The major fate of exogenous choline in lung tissue was previously shown to be incorporation into pulmonary surfactant composed of predominantly phosphatidylcholine [28] . The present data are consistent with this report. choline, but the quantitative importance of these differences is less in these tissues considering the lower levels (<8%) of radioactivity associated with the lipid fraction.
The uptake of choline radiotracers by muscle was low; however, an increase in uptake was seen over the first 20 min postinjection. Because greater than 50% of plasma radioactivity is in the form of radiolabeled betaine after 5 min postinjection, the increased amount of radioactivity in muscle may reflect uptake of betaine metabolites in muscle. Also, synthesis of phosphoglycerides involving the cytidine diphosphate-choline pathway has been reported in muscle which could support accumulation of tracers in muscles [29, 30] .
Uptake of both tracers in subcutaneous 9L tumor was low relative to kidney, liver, and lung, with no differences noted between It is suggested that hypoxia can explain the low levels of choline phosphorylation in the 9L glioma tumor model. This notion is further supported by earlier reports by Koch et al. [21] demonstrating extreme levels of hypoxia (median pO 2 value 5.5 mm Hg) resulting from low perfusion in the same subcutaneous 9L tumor. These results of choline tracer studies with this experimental model may best interpolate to human tumors that are characteristically hypoxic. It follows that the utility of choline tracers in the clinical setting may be impacted by tumor hypoxia. Tumors that are hypoxic may exhibit low uptake of choline-based tracers as governed by poor delivery (perfusion), increased efflux of nonmetabolized tracer, and decreased metabolic trapping (phosphorylation). Thus, interpretations of clinical PET images with choline radiotracers should bear in mind that choline tracer uptake may underestimate tumor proliferation (or viability) in hypoxic tumor regions. 18 F]FCH may serve as a useful radiotracer for noninvasive assessment of choline uptake and metabolism in in vivo studies. The finding of dramatically reduced choline tracer phosphorylation in hypoxic 9L glioma cells, corroborating earlier findings from this laboratory in PC-3 cancer cells, suggests that tumor hypoxia may profoundly lower choline metabolic trapping in cancer cells. Thus, choline tracer retention may be related to tumor oxygenation status through effects on choline kinase activity. This effect has clear implications for interpretation of clinical PET images with choline radiotracers; tumor proliferation (or viability) may be underestimated in hypoxic tumor regions.
Conclusions
